These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1539286)

  • 21. Induction of HLA class II antigen and interleukin 2 receptor expression in acute vascular rejection of human kidney allografts.
    von Willebrand E; Salmela K; Isoniemi H; Krogerus L; Taskinen E; Häyry P
    Transplantation; 1992 May; 53(5):1077-81. PubMed ID: 1585471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The assay of soluble IL-2R receptor levels in graft microenvironment can be helpful in differential diagnosis of transplant dysfunction.
    Yussim A; Shapira Z; Shohat B; Shmueli D; Zingerman B; Livne E; Klein T
    Transplant Proc; 1991 Feb; 23(1 Pt 1):260-2. PubMed ID: 1990528
    [No Abstract]   [Full Text] [Related]  

  • 23. Analysis of the IL-2 receptor by monoclonal antibody of fine needle aspiration specimens.
    Helderman JH; Hernandez J; Glennie J; Womble D
    Transplant Proc; 1989 Aug; 21(4):3574-5. PubMed ID: 2669245
    [No Abstract]   [Full Text] [Related]  

  • 24. The granule exocytosis and Fas/FasLigand pathways at the time of transplantation and during borderline and acute rejection of human renal allografts.
    Carstens J; Markussen N; Madsen M
    Transplant Proc; 2005 Oct; 37(8):3294-7. PubMed ID: 16298578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional assessment of immune markers of graft rejection: a comprehensive study in live-related donor renal transplantation.
    Panigrahi A; Deka R; Bhowmik D; Dash SC; Tiwari SC; Guleria S; Mehta SN; Mehra NK
    Clin Transplant; 2006; 20(1):85-90. PubMed ID: 16556160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid immunodiagnosis of kidney rejection by using activation markers on kidney tubular cells and infiltrating T subset cells.
    Tötterman TH; Hanås E; Larsson E; Lindgren PG; Sjöberg O; Wahlberg J; Tufveson G
    Transplant Proc; 1987 Oct; 19(5):3570-1. PubMed ID: 3313860
    [No Abstract]   [Full Text] [Related]  

  • 27. Expression of class II antigens in human renal allografts: comparison of acute rejection, chronic rejection, and cyclosporine nephrotoxicity.
    Toma H; Tanabe K; Oba S; Horita S; Takahashi K; Teraoka S; Ota K
    Transplant Proc; 1987 Oct; 19(5):3719-20. PubMed ID: 3313898
    [No Abstract]   [Full Text] [Related]  

  • 28. Hyperacute rejection from antibody against class II HLA antigens.
    Ghasemian SR; Light JA; Sasaki TA; Barhyte DY
    Clin Transplant; 1998 Dec; 12(6):569-71. PubMed ID: 9850452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of adhesion molecules in allograft renal dysfunction: a distinct diagnostic pattern in rejection and cyclosporine nephrotoxicity.
    Mampaso F; Marcen R; Molina A; Pascual J; Martin A; Bricio T
    Transplant Proc; 1994 Oct; 26(5):2859-60. PubMed ID: 7524222
    [No Abstract]   [Full Text] [Related]  

  • 30. HLA-DR expression in fine-needle aspiration biopsy cell samples as a marker of rejection in kidney grafts.
    Goldberg J; Rial M; Casadei D; Vila N; Zarazaga CN; Mainetti L
    Transplant Proc; 1988 Aug; 20(4):612-3. PubMed ID: 3043816
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of anti-IL-2-receptor monoclonal antibody BT 563 in treatment of acute interstitial renal rejection.
    Carl S; Wiesel M; Daniel V; Staehler G
    Transplant Proc; 1995 Feb; 27(1):854-5. PubMed ID: 7879205
    [No Abstract]   [Full Text] [Related]  

  • 32. [Changes in class II (HLA-D) antigen expression on T-lymphocytes in the recipients of allogeneic kidney transplants].
    Nowaczyk M; Małdyk-Durlik M; Morzycka-Michalik M; Modlińska M; Lao M; Górski A
    Pol Arch Med Wewn; 1988; 80(2-3):83-7. PubMed ID: 3271317
    [No Abstract]   [Full Text] [Related]  

  • 33. HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies.
    Wissing KM; Fomegné G; Broeders N; Ghisdal L; Hoang AD; Mikhalski D; Donckier V; Vereerstraeten P; Abramowicz D
    Transplantation; 2008 Feb; 85(3):411-6. PubMed ID: 18322434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal target structures in acute allograft rejection.
    Leszczynski D; Laszczynska M; Halttunen J
    Transplant Proc; 1987 Feb; 19(1 Pt 1):378. PubMed ID: 3079159
    [No Abstract]   [Full Text] [Related]  

  • 35. Origin of elevated IL-2 and IL-2R in the urine of rejecting renal allograft recipients.
    Simpson MA; Madras PN; Cornaby AJ; Dempsey RA; Monaco AP
    Transplant Proc; 1989 Feb; 21(1 Pt 1):299-300. PubMed ID: 2650126
    [No Abstract]   [Full Text] [Related]  

  • 36. Cells infiltrating rejected human kidney allografts secrete IFN-gamma, IL-6, and IL-10, and are modulated by IL-2 and IL-4.
    Merville P; Pouteil-Noble C; Wijdenes J; Potaux L; Touraine JL; Banchereau J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):111-3. PubMed ID: 8438243
    [No Abstract]   [Full Text] [Related]  

  • 37. Vascular expression of adhesion molecules in acute and chronic rejection of kidney allografts.
    Jurcić V; Ferluga D
    Adv Clin Path; 2003 Jan; 7(1):33-7. PubMed ID: 19774735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the IL-2 receptor (p55 and p75) on peripheral blood lymphocytes in renal transplant recipients.
    Fujiwara T; Sakagami K; Niguma T; Haisa M; Kawamura T; Kusaka S; Matsuoka J; Shiozaki S; Fujiwara T; Onoda T
    Transplant Proc; 1991 Feb; 23(1 Pt 1):256-9. PubMed ID: 1824979
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of kidney-specific peptides and their role in renal allograft rejection.
    Poindexter NJ; Naziruddin B; Oppat W; Flye MW; Mohanakumar T
    Transplant Proc; 1995 Feb; 27(1):900-2. PubMed ID: 7879223
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.